Up Close with Mosunetuzumab
Last Updated: May 16, 2025
Discover more about mosunetuzumab-axgb (LUNSUMIO™).
Related Resources:
PQI
PQI: Initiating Mosunetuzumab-axgb (Lunsumio) in Relapsed/Refractory Follicular Lymphoma
Last Updated: 07/17/2025
Perspectives
OncolyticsToday: The Bispecific Antibody Revolution
Author: KELLY BRUNK
Last Updated: 04/01/2024
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)
Last Updated: 02/19/2026
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
Up Close with Linvoseltamab
Last Updated: 05/16/2025
PQI Podcast
PQI Podcast
Patient Education Sheet
Patient Education Sheet
S10 E1: Connecting Oncology Care Across Borders
Last Updated: 03/03/2026
S10 E2: Bringing Care Closer to Home: Advancing Rural Oncology
Last Updated: 03/03/2026
Zenocutuzumab
Last Updated: 02/10/2026
Zanidatamab
Last Updated: 02/10/2026